These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7827779)

  • 21. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow.
    Neudorf SM; Rybka W; Ball E; Blatt J; Bloom E; Corey S; deMagalhaes-Silverman M; Koehler M; Lister J; Mierski J; Mirro J; Pincus S; Wilson J; Wollman M; Donnenberg AD
    J Hematother; 1997 Aug; 6(4):351-9. PubMed ID: 9377073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
    Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
    Leelasiri A; Greer JP; Stein RS; Goodman S; Brandt SA; Edwards JR; Wolff SN
    Bone Marrow Transplant; 1995 Mar; 15(3):401-5. PubMed ID: 7599565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
    Bacigalupo A; Hows J; Gordon-Smith EC; Gluckman E; Van Lint MT; Congiu M; James DC; Barrett AJ; Gmur J; De Planque MM
    Bone Marrow Transplant; 1988 Nov; 3(6):531-5. PubMed ID: 3063321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
    Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
    Bone Marrow Transplant; 1995 Apr; 15(4):619-25. PubMed ID: 7655390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings.
    Camitta B; Ash R; Menitove J; Murray K; Lawton C; Hunter J; Casper J
    Blood; 1989 Oct; 74(5):1852-7. PubMed ID: 2529004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A clinical study of 19 cases of unrelated heterogenic bone marrow transplantation].
    Xu L; Huang X; Ren H; Zhang Y; Guo N; Lu D
    Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):256-8. PubMed ID: 12133439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
    Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J
    Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation.
    Gordon BG; Strandjord SE; Warkentin PI; Kadushin J; Coccia PF
    Am J Pediatr Hematol Oncol; 1991; 13(1):29-33. PubMed ID: 2029074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of CML with unrelated donor marrow transplant.
    McGlave P
    Leuk Lymphoma; 1993; 11 Suppl 1():209-11. PubMed ID: 8251898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.
    Bunin NJ; Casper JT; Chitambar C; Hunter J; Truitt R; Menitove J; Camitta BM; Ash R
    J Clin Oncol; 1988 Dec; 6(12):1851-5. PubMed ID: 3058877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
    Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
    Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
    Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
    Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
    Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
    Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
    Bertz H; Potthoff K; Mertelsmann R; Finke J
    Bone Marrow Transplant; 1997 Jun; 19(12):1169-73. PubMed ID: 9208109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.